ULBI

ULTRALIFE CORP (ULBI) - Q3 2025 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2025. Ultralife Corporation designs and manufactures power solutions (batteries, charging systems) and communications systems for government, defense, and commercial sectors. The reporting period includes the full impact of the Electrochem Solutions, Inc. acquisition, which closed on October 31, 2024. The company is currently undergoing a rebranding initiative to consolidate sub-brands under the "Ultralife" master brand.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Q3 revenue increased 21.5% year-over-year, driven primarily by the inclusion of Electrochem sales ($6.8M). Excluding Electrochem, organic commercial sales declined 5.7% due to weakness in medical and oil & gas sectors, while government/defense sales grew 16.4%.
• Margin Compression: Gross margin declined 210 basis points in Q3 (22.2% vs 24.3%) due to unfavorable product mix, quality issues with incoming components, and lower factory throughput. YTD gross margin declined 250 basis points.
• Operating Expenses: Operating expenses rose 29.4% in Q3, largely due to the inclusion of Electrochem operations ($1.3M) and one-time non-recurring costs ($1.1M) related to closing the Calgary facility, acquisition integration, and cyber insurance litigation.
• Interest Expense: Interest and financing expense surged to $0.99M in Q3 (from $0.17M) due to the new $55M Term Loan facility used to finance the Electrochem acquisition.
• Segment Performance: The Battery & Energy Products segment remained the primary revenue driver ($39.9M in Q3), while Communications Systems revenue grew modestly ($3.4M) despite delays in government purchase orders.

Guidance, Outlook, and Risks

• Outlook: Management is focusing on resolving manufacturing inefficiencies, improving supply chain resiliency, and rationalizing operations. Priorities include converting new product development into revenue and advancing vertical integration in the oil & gas segment.
• Rebranding: A comprehensive rebranding initiative is underway to consolidate sub-brands (Accutronics, Southwest Electronic Energy, etc.) under the Ultralife master brand. This will result in a non-cash impairment of tradename and trademark intangible assets to be recorded in Q4 2025.
• Internal Controls: The company disclosed a material weakness in internal control over financial reporting due to a lack of sufficient accounting personnel. Management is remediating this by hiring a Chief Accounting Officer and additional experienced staff, but the weakness was not fully remediated as of September 30, 2025.
• Risks: Key risks include reliance on key customers, potential delays in government spending, supply chain disruptions, raw material cost increases, and the impact of foreign currency fluctuations. The company also faces risks related to the integration of Electrochem and the execution of its rebranding strategy.

Investor Verification Checklist

• Remediation of Material Weakness: Verify the timeline and progress of hiring the Chief Accounting Officer and other key finance roles to ensure the material weakness in internal controls is resolved.
• Electrochem Integration: Monitor the realization of projected synergies and cost efficiencies from the Electrochem acquisition to offset the increased interest burden and operating expenses.
• Margin Recovery: Track the resolution of quality issues with incoming components and factory throughput improvements to determine if gross margins can return to historical levels.
• Debt Covenants: Confirm continued compliance with the fixed charge coverage ratio (1.15:1) and senior leverage ratio (3.50:1) under the new KeyBank Credit Agreement.
• Rebranding Impact: Assess the magnitude of the non-cash impairment charge expected in Q4 2025 related to the consolidation of sub-brands.